Oral health related quality of life in oral submucous fibrosis patients using Ohip tool
An original research
Bibliographic Data
| ID | 15799342 |
|---|---|
| Authors | Mazen Almasri (0000-0001-9642-3523, King Abdulaziz University, corresponding author), Mazen Ahmad Almasri, Tanveer Karpe (Taif University, corresponding author), Kanika Sharma (0000-0002-2066-6382, Panjab University, corresponding author), Meghali Diwaker (corresponding author), Rakshit Vijay Sinai Khandeparker (0000-0003-0809-792X, Goa Dental College and Hospital, corresponding author), S Sunitha (JSS Dental College and Hospital), Navya Dasi (corresponding author) |
| Year | 2022 |
| Pages | 521-527 |
| Publication date | 2022-03-24 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Health Sciences (JOURNAL) |
| Journal identifiers | ISSN: 2550-696X • E-ISSN: 2550-6978 |
| Publisher | Universidad Tecnica de Manabi (PUBLISHER • EC) |
| DOI | 10.53730/ijhs.v6ns2.5006 |
| OpenAlex | W4220783581 |
| Language | EN |
| References cited | 2 |
The objective of the present study was to assess the oral-health-related quality of life (OHRQoL) of oral submucous fibrosis (OSMF) patients. A convenient sampling technique was used to recruit the clinically diagnosed patients of OSMF (n = 50). Based on the medical treatment, the patients were randomly divided into two study groups (group A and B). The group A patients received hyaluronidase (1500 IU) and Group B patients received submucosal intralesional injections of dexamethasone (2 mL; 4 gm/mL). Both the group A and B patients received respective medical therapy biweekly for a period of ten weeks. At the follow up visit (3 months), the impact of treatment on OHRQoL was assessed using the Oral Health Impact Profile-14(OHIP-14). Data were analyzed by a chi-square test for quantitative variables and an independent t-test for qualitative variables. The comparison of all clinical parameters before and after treatment was performed by a paired t-test. The results after treatment showed that there was a significant improvement in all domains of OHIP-14 except psychological disability. In addition, the OHRQoL of patients was significantly improved following the treatment
Group B · Hyaluronidase · Oral health · Oral submucous fibrosis · Quality of life (healthcare · Dentistry · Medicine · Oral Health Pathology and Treatment · Internal Medicine · Surgery
| Citation velocity | historical |
|---|---|
| Highly cited | No |